| RS2140381286 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS2140381317 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS2140382889 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS2140384005 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma, cutaneous malignant |
| RS2140388619 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Melanoma |
| RS2140396112 |
CYP27B1
|
Health Risk |
Likely pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS2140396191 |
CYP27B1
|
Health Risk |
Pathogenic |
— |
| RS2140396224 |
CYP27B1
|
Health Risk |
Likely pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS2140396403 |
CYP27B1
|
Health Risk |
Pathogenic |
— |
| RS2140396410 |
CYP27B1
|
Health Risk |
Likely pathogenic |
Vitamin D-dependent rickets, type 1 |
| RS2140396992 |
CYP27B1
|
Health Risk |
Likely pathogenic |
— |
| RS2140397019 |
CYP27B1
|
Health Risk |
Likely pathogenic |
Vitamin D-dependent rickets, type 1 |
| RS2140397164 |
CYP27B1
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS2140397262 |
CYP27B1
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS2140397587 |
CYP27B1
|
Health Risk |
Likely pathogenic |
Vitamin D-dependent rickets, type 1 |
| RS2140397692 |
CYP27B1
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS2140397731 |
CYP27B1
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS2140398340 |
CYP27B1
|
Health Risk |
Pathogenic |
— |
| RS2140404268 |
COQ6
|
Health Risk |
Pathogenic |
Familial steroid-resistant nephrotic syndrome with sensorineural deafness, Familial steroid-resistant nephrotic syndrome with sensorineural deafness |
| RS2140404355 |
COQ6
|
Health Risk |
Pathogenic |
— |
| RS2140404882 |
COQ6
|
Health Risk |
Pathogenic |
— |
| RS2140412540 |
TSFM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS2140413092 |
TSFM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS2140415380 |
SPG21
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS2140418135 |
TSFM
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS2140422904 |
KIF23
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, type III |
| RS2140424315 |
TSFM
|
Health Risk |
Pathogenic |
— |
| RS2140424344 |
TSFM
|
Health Risk |
Pathogenic |
— |
| RS2140424365 |
TSFM
|
Health Risk |
Pathogenic |
— |
| RS2140424959 |
KIF23
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type III |
| RS2140427422 |
SPG21
|
Health Risk |
Pathogenic |
Mast syndrome, Mast syndrome |
| RS2140428750 |
TSFM
|
Health Risk |
Pathogenic |
— |
| RS2140429730 |
ACTC1
|
Health Risk |
Pathogenic |
— |
| RS2140430561 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 11, Atrial septal defect 5 |
| RS2140430645 |
ACTC1
|
Health Risk |
Likely pathogenic |
Atrial septal defect 5, Atrial septal defect 5 |
| RS2140431879 |
ACTC1
|
Health Risk |
Likely pathogenic |
— |
| RS2140432240 |
ACTC1
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 11, Atrial septal defect 5 |
| RS2140432284 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 11, Dilated cardiomyopathy 1R |
| RS2140433062 |
ATP11A
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 33, Hearing loss |
| RS2140441397 |
SPG21
|
Health Risk |
Likely pathogenic |
Mast syndrome, Mast syndrome |
| RS2140471687 |
CDAN1
|
Health Risk |
Pathogenic |
Anemia, congenital dyserythropoietic |
| RS2140484777 |
MTFMT
|
Health Risk |
Pathogenic |
— |
| RS2140490467 |
CDAN1
|
Health Risk |
Likely pathogenic |
— |
| RS2140493876 |
MTFMT
|
Health Risk |
Pathogenic |
— |
| RS2140493897 |
MTFMT
|
Health Risk |
Pathogenic |
— |
| RS2140496185 |
DPYS
|
Health Risk |
Pathogenic |
— |
| RS2140505826 |
CDAN1
|
Health Risk |
Pathogenic |
Anemia, congenital dyserythropoietic |
| RS2140520299 |
PPFIBP1
|
Health Risk |
Pathogenic |
Microcephaly, Severe intellectual disability |
| RS2140527110 |
ERCC5
|
Health Risk |
Likely pathogenic |
Hepatoblastoma, Hepatoblastoma |
| RS2140536878 |
GABRB3
|
Health Risk |
Pathogenic |
Epilepsy, childhood absence |
| RS2140536891 |
GABRB3
|
Health Risk |
Likely pathogenic |
— |
| RS2140536974 |
GABRB3
|
Health Risk |
Likely pathogenic |
Epilepsy, childhood absence |
| RS2140536988 |
GABRB3
|
Health Risk |
Pathogenic |
Epilepsy, childhood absence |
| RS2140537271 |
GABRB3
|
Health Risk |
Pathogenic |
Epilepsy, childhood absence |
| RS2140538834 |
ERCC5
|
Health Risk |
Pathogenic |
Cerebrooculofacioskeletal syndrome 3, Cerebrooculofacioskeletal syndrome 3 |
| RS2140545943 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 6, Nemaline myopathy 6 |
| RS2140551864 |
DMXL2
|
Health Risk |
Likely pathogenic |
— |
| RS2140558454 |
WDR72
|
Health Risk |
Likely pathogenic |
Distal renal tubular acidosis, Distal renal tubular acidosis |
| RS2140565674 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS2140575082 |
ZMYM2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2140576563 |
ZMYM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, Congenital anomaly of kidney and urinary tract |
| RS2140578834 |
MAP2K1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS2140578916 |
MAP2K1
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS2140579005 |
MAP2K1
|
Health Risk |
Pathogenic/Likely pathogenic |
Parkes Weber syndrome, Vascular malformation |
| RS2140580300 |
SMAD6
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2140580364 |
SMAD6
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2140580751 |
SMAD6
|
Health Risk |
Likely pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2140581013 |
SMAD6
|
Health Risk |
Likely pathogenic |
Abnormal axial skeleton morphology, Radioulnar synostosis |
| RS2140581167 |
SMAD6
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2140581198 |
SMAD6
|
Health Risk |
Pathogenic |
Plagiocephaly, Radioulnar synostosis |
| RS2140581279 |
SMAD6
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2140581496 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2140581633 |
SMAD6
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2140582795 |
SMAD6
|
Health Risk |
Pathogenic |
— |
| RS2140583355 |
MAP2K1
|
Health Risk |
Pathogenic |
— |
| RS2140583383 |
MAP2K1
|
Health Risk |
Pathogenic/Likely pathogenic |
Vascular malformation, Vascular malformation |
| RS2140588007 |
GABRA5
|
Health Risk |
Likely pathogenic |
— |
| RS2140591830 |
TTBK2
|
Health Risk |
Pathogenic |
— |
| RS2140596481 |
SMAD6
|
Health Risk |
Likely pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2140596499 |
SMAD6
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2140596524 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
Radioulnar synostosis, nonsyndromic |
| RS2140619474 |
OCA2
|
Health Risk |
Likely pathogenic |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS2140633558 |
SLC12A6
|
Health Risk |
Likely pathogenic |
— |
| RS2140639518 |
INF2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 5, Focal segmental glomerulosclerosis 5 |
| RS2140641550 |
SLC12A6
|
Health Risk |
Pathogenic/Likely pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS2140641896 |
GATM
|
Health Risk |
Pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2140644856 |
GATM
|
Health Risk |
Likely pathogenic |
— |
| RS2140644920 |
GATM
|
Health Risk |
Likely pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2140646735 |
GATM
|
Health Risk |
Pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2140647207 |
INF2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease dominant intermediate E, Focal segmental glomerulosclerosis 5 |
| RS2140647298 |
INF2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS2140648131 |
INF2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS2140648160 |
INF2
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis, Focal segmental glomerulosclerosis |
| RS2140648522 |
INF2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS2140653469 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2140654428 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2140657166 |
GATM
|
Health Risk |
Likely pathogenic |
Fanconi renotubular syndrome 1, Fanconi renotubular syndrome 1 |
| RS2140664007 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS2140668239 |
MAP2K1
|
Health Risk |
Conflicting classifications of pathogenicity |
MAP2K1-related disorder, RASopathy |
| RS2140668412 |
OCA2
|
Health Risk |
Pathogenic |
— |